HAMILTON THORNE LTD. Hamilton Thorne Ltd. Share Price Deutsche Boerse AG
Equities
0ZM
CA4078911001
Advanced Medical Equipment & Technology
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.99 EUR | +3.12% |
|
-0.50% | +3.66% |
| 06-23 | Hamilton Thorne Maintained at Buy at Stifel GMP on No Impact From U.S. IVF Actions; Price Target Kept at C$2.55 | MT |
| 05-14 | Hamilton Thorne Q1 Loss Widens Even as Sales Increase | MT |
| Sales 2024 * | 79.6M 74.54M 6.31B | Sales 2025 * | 87.16M 81.62M 6.9B | Capitalization | 159M 149M 12.58B |
|---|---|---|---|---|---|
| Net income 2024 * | 2M 1.87M 158M | Net income 2025 * | 5M 4.68M 396M | EV / Sales 2024 * | 2.09 x |
| Net Debt 2024 * | 7.4M 6.93M 586M | Net cash position 2025 * | 3.1M 2.9M 246M | EV / Sales 2025 * | 1.79 x |
| P/E ratio 2024 * |
61.9
x | P/E ratio 2025 * |
29.5
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.66% |
More Fundamentals
* Assessed data
More news
Latest transcript on Hamilton Thorne Ltd.
More press releases
| 1 day | +3.13% | ||
| 1 week | -0.50% | ||
| Current month | +7.61% | ||
| 1 month | +7.61% | ||
| 3 months | +11.86% | ||
| 6 months | +10.00% | ||
| Current year | +3.66% |
1 week
0.94
1.02
1 month
0.921.04
Current year
0.841.04
1 year
0.741.07
3 years
0.741.51
5 years
0.591.51
10 years
0.441.51
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01-14 | |
David Wolf
CHM | Chairman | - | 31/08/11 |
| Director of Finance/CFO | - | 31/08/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Daniel Thorne
BRD | Director/Board Member | - | 27/10/09 |
| Chief Executive Officer | - | 01-14 | |
Kari Firestone
BRD | Director/Board Member | 68 | 17/01/22 |
| Date | Price | Change |
|---|---|---|
| 26/06/24 | 0.99 | +3.12% |
| 25/06/24 | 0.96 | -5.88% |
| 24/06/24 | 1.02 | +6.81% |
| 21/06/24 | 0.955 | -3.54% |
| 20/06/24 | 0.99 | -0.50% |
Delayed Quote Deutsche Boerse AG, June 26, 2024 at 03:55 pm
More quotes
Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and consumables to meet customer requirements. Its branded instrument, equipment and software product lines include precision laser devices, imaging systems, incubators, laminar flow workstations, air purification systems, control rate freezers, lab monitoring systems, and micromanipulation systems. It also offers a portfolio of artificial intelligence (AI)-enabled common astronomy software applications (CASA) software and other product offerings. Its GM501 family of products provides the in vitro fertilization (IVF) lab with comprehensive cell culture media solutions.
Calendar
20/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1.033
USD
Average target price
1.665
USD
Spread / Average Target
+61.26%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.57% | 212B | |
| +10.03% | 188B | |
| +31.08% | 157B | |
| +33.78% | 114B | |
| +3.46% | 64.01B | |
| +1.51% | 48.83B | |
| -4.09% | 39.3B | |
| +1.71% | 35.97B | |
| +8.02% | 27B |
- Stock Market
- Equities
- HTL Stock
- 0ZM Stock
